Short-term pain. Long term gain.08 Feb 2022 15:31
This one photo says it all for me and why I firmly believe AVCT may have a potential Cancer CURE, not just a treatment on their hands.
If they can replicate it in human trials which I believe they will (hence the further dosing of AVA6000) then I believe they will be bought out long before they complete the trials for an absolutely MASSIVE amount of money.
Remember that a company called Ablynx had a very similar drug platform called "Nanobodies" which is very similar to AVCTs
"Precision" platform in that its not a drug for just one disease,it's a Platform that can help multiple diseases.
Ablynx were bought out by Sanofi during their clinical trials phase for $4.8 billion in a bidding war in 2018.
https://www.reuters.com/article/idUSKBN1FI0OS
So the question is how much would someone pay for a company with a potential Cancer CURE if Ablynx were bought out for $4.8 billion ?
The next question is do you think AVCT may have a potential Cancer CURE?
For me the answer is yes if they can replicate their incredible success on Cancer tumors in humans.
Here is that one photo I mentioned at the beginning which says everything I need to know for me:
https://ibb.co/1rMFD6c
Once the LFT investors are finally out and only Cancer therapy investors are left the company will begin to re-rate, and deservedly so imho.
Until then though it's anyones guess how low this could go in the short term. It could,and probably will ,go much further down short-term and may take several months or the rest of the year to begin the recovery.
But OMG...the long term !